AID  Vol.3 No.1 , March 2013
Estimates of Genetic Variability of Mycobacterium tuberculosis Complex and Its Association with Drug Resistance in Cameroon
Abstract: The present study investigates the genetic diversity among Mycobacterium tuberculosis complex circulating in the Centre region of Cameroon and analyzes the relationship between genotypes and drug resistance patterns. Spoligotyping was performed by PCR-amplification followed by the reverse hybridization of 298 cultured specimens. Spoligotypes patterns were identified by comparison to reference strains in SPolDB4 database via the MIRU VNTR plus web application. About 97.65% of all tuberculosis (TB) cases were attributed to M. tuberculosis. A total of 65 different profiles were identified. Of these, 40 were represented as Shared Types (ST) while the others were orphans. LAM10_CAM and Haarlem families were the most prevalent genetic families with 51.01% and 14.09% respectively. ST 61, a member of the LAM10_ CAM family formed the largest cluster with 128 (42.95%) isolates. No association was found between genotypes with regard to drug resistance and HIV sero-status. However, there was a significant association between genotypes and age groups. Patients belonging to 15 - 24 and 35 - 44 age groups were more likely infected by LAM10_CAM strains compared to others. The population structure of Mycobacterium tuberculosis complex strains from the Centre region was found to be diverse and the spoligotype 61 of the LAM10_CAM family was highly predominant. Isolates of the LAM10_CAM seem to be not associated with drug resistance.
Cite this paper: L. Kamgue Sidze, E. Mouafo Tekwu, C. Kuaban, J. Assam Assam, J. Tedom, S. Niemann, M. Frank and V. N. Penlap Beng, "Estimates of Genetic Variability of Mycobacterium tuberculosis Complex and Its Association with Drug Resistance in Cameroon," Advances in Infectious Diseases, Vol. 3 No. 1, 2013, pp. 55-59. doi: 10.4236/aid.2013.31007.

[1]   C. Dye, “Global epidezmiology of tuberculosis,” Lancet, Vol. 367, No. 9514, 2006, pp. 938-940. doi:10.1016/S0140-6736(06)68384-0

[2]   K. Rowland, “Totally Drug-Resistant TB Emerges in India,” Nature News and Comment, 13 January 2012.

[3]   World Health Organization, “Global Tuberculosis Control: WHO Report 2011,” Geneva, 2011.

[4]   G. D. Van der Spuy, R. M. Warren and P. D. Van Helden, “The Role of Molecular Epidemiology in Low-Income, High-Burden Countries,” International Journal of Tubercle and Lung Diseases, Vol. 13, No. 4, 2009, pp. 419-420.

[5]   D. Van Soolingen, P. W. Hermans, P. E. De Haas, D. R. Soll and J. D. Van Embden, “Occurrence and Stability of Insertion Sequences in Mycobacterium tuberculosis Complex Strains: Evaluation of an Insertion Sequence-Dependent DNA Polymorphism as a Tool in the Epidemiology of Tuberculosis,” Journal of Clinical Microbiology, Vol. 29, No. 11, 1991, pp. 2578-2586.

[6]   J. Kamerbeek, L. Schouls, A. Kolk, M. Van Agterveld, D. Van Soolingen, S. Kuijper, A. Bunschoten, H. Molhuizen, R. Shaw, M. Goyal, et al., “Simultaneous Detection and Strain Differentiation of Mycobacterium tuberculosis for Diagnosis and Epidemiology,” Journal of Clinical Microbiology, Vol. 35, No. 4, 1997, pp. 907-914. doi:10.3201/eid0811.020125

[7]   I. Filliol, J. R. Driscoll, D.Van Soolingen, B. N. Kreiswirth, K. Kremer, G. Valetudie, D. D. Anh, R. Barlow, D. Banerjee, P. J. Bifani, et al., “Global Distribution of Mycobacterium tuberculosis Spoligotypes,” Emerging Infectious Diseases, Vol. 8, No. 11, 2002, pp. 1347-1349.

[8]   T. Weniger, J. Krawczyk, P. Supply, S. Niemann and D. Harmsen, “MIRU-VNTR plus: A Web Tool for Polyphasic Genotyping of Mycobacterium tuberculosis Complex Bacteria,” Nucleic Acids Research, Vol. 38, 2010, pp. W326-W331.

[9]   P. R. Hunter and M. A. Gaston, “Numerical Index of the Discriminatory Ability of Typing Sysems: An Application of Simpson’s Index of Diversity,” Journal of Clinical Microbiology, Vol. 26, No. 1, 1988, pp. 2465-2466.

[10]   B. Mathema, N. E. Kurepina, P. J. Bifani and B. N. Kreiswirth, “Molecular Epidemiology of Tuberculosis: Current Insights,” Clinical Microbiology Review, Vol. 19, No. 4, 2006, pp. 658-685. doi:10.1128/CMR.00061-05

[11]   S. N. Niobe-Eyangoh, C. Kuaban, P. Sorlin, P. Cunin, J. Thonnon, C. Sola, et al., “Genetic Biodiversity of Mycobacterium tuberculosis Complex Strains from Patients with Pulmonary Tuberculosis in Cameroon,” Journal of Clinical Microbiology, Vol. 41, No. 6, 2003, pp. 2547-2553. doi:10.1128/JCM.41.6.2547-2553.2003

[12]   S. Godreuil, G. Torrea, D. Terru, F. Chevenet, S. Diagbouga, P. Supply, et al., “First Molecular Epidemiology Study of Mycobacterium tuberculosis in Burkina Faso,” Journal of Clinical Microbiology, Vol. 45, No. 3, 2007, pp. 921-927. doi:10.1128/JCM.01918-06

[13]   D. Affolabi, G. Anyo, F. Faihun, N. Sanoussi, I. C. Shamputa, L. Rigouts, et al., “First Molecular Epidemiological Study of Tuberculosis in Benin,” International Journal of Tubercle and Lung Diseases, Vol. 13, No. 13, 2009, pp. 317-322.

[14]   S. Homolka, E. Post, B. Oberhauser, A. G. George, L. Westman, F. Dafae, S. Rusch-Gerdes and S. Niemann, “High Genetic Diversity among Mycobacterium tuberculosis Complex Strains from Sierra Leone,” BMC Microbiology, Vol. 8, No. 103, 2008, pp. 489-495.

[15]   A. Namouchi, A. Karboul, B. Mhenni, N. Khabouchi, R. Haltiti, R. Ben Hassine, et al., “Genetic Profiling of Mycobacterium tuberculosis in Tunisia: Predominance and Evidence for the Establishment of a Few Genotypes,” Journal of Medical Microbiology, Vol. 57, No. 7, 2008, pp. 864-872. doi:10.1099/jmm.0.47483-0

[16]   P. Supply, E. Mazars, S. Lesjean, V. Vincent, B. Gicquel and C. Locht, “Variable Human Minisatellite-Like Regions in the Mycobacterium tuberculosis Genome,” Molecular Microbiology, Vol. 36, No. 3, 2000, pp. 762-771. doi:10.1046/j.1365-2958.2000.01905.x

[17]   W. A. Githui, A. M. Jordaan, E. S. Juma, P. Kinyanjui, F. G. Karimi, J. Kimwomi, et al., “Identification of MDRTB Beijing/W and Other Mycobacterium tuberculosis Genotypes in Nairobi, Kenya,” International Journal of Tubercle and Lung Diseases, Vol. 8, No. 3, 2004, pp. 352-360.

[18]   S. Gagneux and P. M. Small, “Global Phylogeography of Mycobacterium tuberculosis and Implications for Tuberculosis Product Development,” Lancet Infectious Diseases, Vol. 7, No. 5, 2007, pp. 328-337. doi:10.1016/S1473-3099(07)70108-1